dRx series: Deprescribing medicines used for benign prostatic hyperplasia in older people

When should pharmacists consider deprescribing an older patient’s medicines for benign prostatic hyperplasia (BPH)? Amanda Quek and Dr Amy Page take a look Deprescribing is defined as a person-centred process of medication withdrawal intended to achieve improved health outcomes through discontinuation of one or more medications that are either potentially harmful or no longer required.